Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Beyond appetite regulation: Targeting energy expenditure, fat oxidation, and lean mass preservation for sustainable weight loss
Berit Østergaard Christoffersen, Guillermo Sánchez‐Delgado, Linu M. John, et al.
Obesity (2022) Vol. 30, Iss. 4, pp. 841-857
Open Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

GDF15 promotes weight loss by enhancing energy expenditure in muscle
Dongdong Wang, Logan K. Townsend, Geneviève J. DesOrmeaux, et al.
Nature (2023) Vol. 619, Iss. 7968, pp. 143-150
Open Access | Times Cited: 109
Mechanisms and possible hepatoprotective effects of glucagon-like peptide-1 receptor agonists and other incretin receptor agonists in non-alcoholic fatty liver disease
Giovanni Targher, Alessandro Mantovani, Christopher D. Byrne
˜The œLancet. Gastroenterology & hepatology (2023) Vol. 8, Iss. 2, pp. 179-191
Open Access | Times Cited: 73
Obesity-induced and weight-loss-induced physiological factors affecting weight regain
Marleen A. van Baak, Edwin C.M. Mariman
Nature Reviews Endocrinology (2023) Vol. 19, Iss. 11, pp. 655-670
Closed Access | Times Cited: 41
Changes in lean body mass with glucagon‐like peptide‐1‐based therapies and mitigation strategies
Ian J. Neeland, Jennifer Linge, Andreas L. Birkenfeld
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. S4, pp. 16-27
Closed Access | Times Cited: 38
Incretin-Based Weight Loss Pharmacotherapy: Can Resistance Exercise Optimize Changes in Body Composition?
João Carlos Locatelli, Juliene Gonçalves Costa, Andrew Haynes, et al.
Diabetes Care (2024) Vol. 47, Iss. 10, pp. 1718-1730
Open Access | Times Cited: 26
Antibody blockade of activin type II receptors preserves skeletal muscle mass and enhances fat loss during GLP-1 receptor agonism
Elizabeth de Fougerolles Nunn, Natasha Jaiswal, Matthew Gavin, et al.
Molecular Metabolism (2024) Vol. 80, pp. 101880-101880
Open Access | Times Cited: 23
A cellular and molecular basis of leptin resistance
Bowen Tan, Kristina Hedbacker, Leah Kelly, et al.
Cell Metabolism (2025) Vol. 37, Iss. 3, pp. 723-741.e6
Open Access | Times Cited: 2
Sarcopenia and Diabetes: A Detrimental Liaison of Advancing Age
Giuseppe Lisco, Olga Disoteo, Anna De Tullio, et al.
Nutrients (2023) Vol. 16, Iss. 1, pp. 63-63
Open Access | Times Cited: 29
Hypothalamic control of body fat mass by food intake: The key to understanding why obesity should be treated as a disease
Jonathan Q. Purnell, Carel W. le Roux
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. S2, pp. 3-12
Open Access | Times Cited: 9
NK2R control of energy expenditure and feeding to treat metabolic diseases
Frederike Sass, Tao Ma, Jeppe H. Ekberg, et al.
Nature (2024) Vol. 635, Iss. 8040, pp. 987-1000
Open Access | Times Cited: 9
New Insights into Mitochondria in Health and Diseases
Ya Li, Huhu Zhang, Chunjuan Yu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 9975-9975
Open Access | Times Cited: 8
Muscle Mass and Glucagon-Like Peptide-1 Receptor Agonists: Adaptive or Maladaptive Response to Weight Loss?
Jennifer Linge, Andreas L. Birkenfeld, Ian J. Neeland
Circulation (2024) Vol. 150, Iss. 16, pp. 1288-1298
Closed Access | Times Cited: 8
Mediators of Amylin Action in Metabolic Control
Christina N. Boyle, Yi Zheng, Thomas A. Lutz
Journal of Clinical Medicine (2022) Vol. 11, Iss. 8, pp. 2207-2207
Open Access | Times Cited: 30
mTORC1 in energy expenditure: consequences for obesity
C. Allard, Cristina Miralpeix, Antonio J. López-Gambero, et al.
Nature Reviews Endocrinology (2024) Vol. 20, Iss. 4, pp. 239-251
Closed Access | Times Cited: 6
Glucagon‐like peptide‐1/glucagon receptor agonism associates with reduced metabolic adaptation and higher fat oxidation: A randomized trial
Karen D. Corbin, Elvis Á. Carnero, Timothy D. Allerton, et al.
Obesity (2023) Vol. 31, Iss. 2, pp. 350-362
Open Access | Times Cited: 14
Impact of Selected Glucagon-like Peptide-1 Receptor Agonists on Serum Lipids, Adipose Tissue, and Muscle Metabolism—A Narrative Review
Zsolt Szekeres, András Nagy, K. Jahner, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8214-8214
Open Access | Times Cited: 5
Measuring energy expenditure in Göttingen Minipigs using indirect calorimetry: validation and methodological considerations
Simon K. Bredum, Julie Jacobsen, Susanna Cirera, et al.
Laboratory Animal Research (2025) Vol. 41, Iss. 1
Open Access
Weight Reduction with GLP-1 Agonists and Paths for Discontinuation While Maintaining Weight Loss
Allison B. Reiss, Shelly Gulkarov, Raymond Lau, et al.
Biomolecules (2025) Vol. 15, Iss. 3, pp. 408-408
Open Access
Isolation and identification of a novel bisacodyl analogue, bisacodyl dicycloproyl carboxylate, as a potential illegal additive in a dried plum product advertised for weight loss
Xianxian Li, Feng Jiang, Hong Yu, et al.
Food Additives & Contaminants Part A (2025), pp. 1-8
Closed Access
Physiology of Weight Regain after Weight Loss: Latest Insights
Marleen A. van Baak, Edwin C.M. Mariman
Current Obesity Reports (2025) Vol. 14, Iss. 1
Open Access
Tirzepatide did not impact metabolic adaptation in people with obesity, but increased fat oxidation
Éric Ravussin, Guillermo Sánchez‐Delgado, Corby K. Martin, et al.
Cell Metabolism (2025)
Closed Access
The promise of tirzepatide: A narrative review of metabolic benefits
Sara Sokary, Hiba Bawadi
Primary care diabetes (2025)
Open Access
The Goldilocks for chronic weight management—Balancing quantity with quality of weight loss
Kim Henriksen, Manu V. Chakravarthy, Cecilie Liv Bager, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access
Proportion of caloric restriction‐induced weight loss as skeletal muscle
Steven B. Heymsfield, Shengping Yang, Cassidy McCarthy, et al.
Obesity (2023) Vol. 32, Iss. 1, pp. 32-40
Closed Access | Times Cited: 12
Page 1 - Next Page

Scroll to top